Probity Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.68M Buy
304,095
+160,414
+112% +$4.09M 1.22% 18
2025
Q4
$3.67M Sell
143,681
-1,517
-1% -$38.8K 0.59% 35
2025
Q3
$3.72M Buy
145,198
+2,935
+2% +$74.5K 0.6% 37
2025
Q2
$3.6M Buy
142,263
+11,266
+9% +$280K 0.63% 38
2025
Q1
$3.27M Buy
130,997
+7,570
+6% +$187K 0.63% 36
2024
Q4
$3.03M Buy
123,427
+22,109
+22% +$553K 0.58% 36
2024
Q3
$2.6M Buy
101,318
+12,024
+13% +$304K 0.5% 45
2024
Q2
$2.19M Buy
89,294
+18,003
+25% +$440K 0.45% 49
2024
Q1
$1.77M Buy
71,291
+33,143
+87% +$821K 0.37% 59
2023
Q4
$962K Buy
+38,148
New +$910K 0.21% 93

Other funds holding IBDX

Probity Advisors's IBDX Position: Q1 2026 in Review

Probity Advisors increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 112% in Q1 2026, buying an estimated $4.09M and bringing the position to 304,095 shares worth $7.68M. The position accounts for 1.22% of the portfolio, ranked #18.

Probity Advisors first reported a position in IBDX in Q4 2023 and has held it in 10 quarters since. 221 funds tracked by Wall St. Rank hold IBDX as of Q1 2026.

  • Probity Advisors held 304,095 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $7.68M as of Q1 2026.
  • Probity Advisors bought 160,414 iShares iBonds Dec 2032 Term Corporate ETF shares in Q1 2026, an estimated $4.09M.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 1.22% of Probity Advisors's portfolio in Q1 2026, its #18 holding.
  • Probity Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2023 and has held it in 10 quarters since.
  • 221 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2026.

Based on Probity Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.